165 related articles for article (PubMed ID: 31523745)
1. The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes.
Zotz RB; Poon MC; Di Minno G; D'Oiron R;
TH Open; 2019 Jul; 3(3):e286-e294. PubMed ID: 31523745
[No Abstract] [Full Text] [Related]
2. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
Poon MC; d'Oiron R; Zotz RB; Bindslev N; Di Minno MN; Di Minno G;
Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
[TBL] [Abstract][Full Text] [Related]
3. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Di Minno G; Zotz RB; d'Oiron R; Bindslev N; Di Minno MN; Poon MC;
Haematologica; 2015 Aug; 100(8):1031-7. PubMed ID: 26001793
[TBL] [Abstract][Full Text] [Related]
4. New Insights Into the Treatment of Glanzmann Thrombasthenia.
Poon MC; Di Minno G; d'Oiron R; Zotz R
Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
[TBL] [Abstract][Full Text] [Related]
5. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
Recht M; Rajpurkar M; Chitlur M; d'Oiron R; Zotz R; Di Minno G; Cooper DL; Poon MC
Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
[TBL] [Abstract][Full Text] [Related]
6. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
Poon MC
Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
[TBL] [Abstract][Full Text] [Related]
7. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.
Rajpurkar M; Chitlur M; Recht M; Cooper DL
Haemophilia; 2014 Jul; 20(4):464-71. PubMed ID: 24948404
[TBL] [Abstract][Full Text] [Related]
9. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
Di Minno G
Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
[TBL] [Abstract][Full Text] [Related]
10. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
Levy-Mendelovich S; Levy T; Budnik I; Barg AA; Rosenberg N; Seligsohn U; Kenet G; Livnat T
Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
[TBL] [Abstract][Full Text] [Related]
11. Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy.
Ogawa Y; Kunishima S; Yanagisawa K; Osaki Y; Uchiyama Y; Matsumoto N; Tokiniwa H; Horiguchi J; Nojima Y; Handa H
Int J Hematol; 2017 Feb; 105(2):221-225. PubMed ID: 27696190
[TBL] [Abstract][Full Text] [Related]
12. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
Balci YI; Karabulut A; Kabukcu S; Sari I; Keskin A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
[TBL] [Abstract][Full Text] [Related]
13. Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.
Lee A; Maier CL; Batsuli G
Haemophilia; 2022 Jul; 28(4):633-641. PubMed ID: 35412688
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
Poon MC; D'Oiron R; Von Depka M; Khair K; Négrier C; Karafoulidou A; Huth-Kuehne A; Morfini M;
J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
[TBL] [Abstract][Full Text] [Related]
15. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
16. Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disorders.
Chitlur M; Rajpurkar M; Recht M; Tarantino MD; Yee DL; Cooper DL; Gunawardena S
Int J Gen Med; 2017; 10():95-99. PubMed ID: 28435309
[TBL] [Abstract][Full Text] [Related]
17. Severe Intestinal Bleeding in a Woman with Glanzmann Thrombasthenia.
Mesquita R; Santos I; Monteiro H
Eur J Case Rep Intern Med; 2018; 5(2):000796. PubMed ID: 30756012
[TBL] [Abstract][Full Text] [Related]
18. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
Valentino LA
J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
[TBL] [Abstract][Full Text] [Related]
19. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
Poon MC
Vasc Health Risk Manag; 2007; 3(5):655-64. PubMed ID: 18078017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
